The scoring system used in the present study, whereby both intensity and distribution are measured, is useful for evaluating the role of FAAH in the pathogenesis of prostate cancer, which was the aim of the present study, but may be too complex for routine clinical diagnosis, where a simple intensity score would be preferable. The gene discussed is FAAH; the disease is prostate cancer.